Throat Cancer Market Trends Analysis By DelveInsight
Throat Cancer is cancer that develops in the mouth, voice box, base of the tongue, sinus and nasal cavities, salivary glands, tonsils, soft palate and lymph nodes in the neck. Throat cancer is of two types namely pharyngeal cancer and laryngeal cancer. As per the American Cancer Society, in 2021, an estimated 54,010 new cases of cancer of the oral cavity and pharynx (throat) will be diagnosed in the US and 10,850 people will die from the disease. It is observed that Incidence rates of Throat Cancer are more than twice as high in men as in women.
Persistent sore throat is one of the most common signs of Throat Cancer. The common symptoms of throat cancer include a chronic cough, change in voice, or pain in the throat or ear. Similarly, difficulty in swallowing, lumps or swelling in the throat or lymph nodes are some other symptoms. The treatment option for the throat cancer includes chemotherapy, surgery, targeted therapy drugs, and radiation therapy. The treatment procedure for Throat Cancer depends upon the location, stage, and grade of cancer. The age and the health of the affected person are also considered for treatment.
DelveInsight's "Throat Cancer Market Insights, Epidemiology, and Market Forecast 2030" reports deliver an in-depth understanding of the Throat Cancer Market, historical and forecasted epidemiology, the pipeline insight as well as the Throat Cancer market size and shares analysis in the seven major markets (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
The Throat Cancer market analysis section of the report helps to build a detailed comprehension of the historical, current, and forecasted Throat Cancer market trends and growth by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers and demand for better technology. The report gives complete detail of Throat Cancer market size and shares of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
The key companies in the Throat Cancer market include Pfizer, Bristol-Myers Squibb, Novartis Pharmaceuticals, Teva Pharmaceutical, Eli Lilly and Company, Hoffmann-La Roche, Celgene Corporation, and many others. In the coming years, tobacco use, alcohol consumption, and increasing awareness will drive the Throat Cancer market growth.
Throat Cancer Epidemiology Forecast
The Throat Cancer epidemiology section covers insights about historical and current Throat Cancer patient pool and forecasted trends for every seven major countries (i.e., the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan. It helps to recognize the causes of current and forecasted Throat Cancer Epidemiology trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends, along with assumptions undertaken.
For more details, visit: Throat Cancer Market Trends